|
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal |
|
|
|
Titel: |
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal |
Auteur: |
Rollot, Fabien Couturier, Justine Casey, Romain Wiertlewski, Sandrine Debouverie, Marc Pelletier, Jean De Sèze, Jérôme Labauge, Pierre Ruet, Aurélie Thouvenot, Eric Ciron, Jonathan Berger, Eric Gout, Olivier Clavelou, Pierre Stankoff, Bruno Casez, Olivier Bourre, Bertrand Zephir, Hélène Moreau, Thibault Lebrun-Frenay, Christine Maillart, Elisabeth Edan, Gilles Neau, Jean-Philippe Montcuquet, Alexis Cabre, Philippe Camdessanché, Jean-Philippe Defer, Gilles Nasr, Haifa Ben Maurousset, Aude Hankiewicz, Karolina Pottier, Corinne Leray, Emmanuelle Vukusic, Sandra Laplaud, David-Axel |
Verschenen in: |
Neurotherapeutics |
Paginering: |
Jaargang 19 () nr. 2 pagina's 476-490 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
The American Society for Experimental NeuroTherapeutics, Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|